Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Scorpion Therapeutics, a wholly owned subsidiary of Eli Lilly and Company
Age
18–55
Sex
MALE
Healthy volunteers
Accepted
You may be eligible if
Body mass index (BMI) ≥ 18.0 kg/m2 and ≤ 32.0 kg/m2 at Screening; body weight
≥ 55.0 kg and ≤ 100.0 kg at Screening.
Negative serology results for hepatitis B surface antigen (HBsAg), hepatitis C virus antibody (HCV Ab) and human immunodeficiency virus antibody and antigen (HIV Ab/Ag).
Non-smoker (with no use of other tobacco or nicotine containing products, in any form), as documented by history (no nicotine within 6 months prior to Screening) and a negative cotinine test at Screening and admission
You may not be if
History or presence of any diseases or conditions of clinical significance by the Investigator (or designee) and/or Sponsor
Any history of serious allergic/hypersensitivity reactions
History or presence of alcohol or drug abuse (self-reported) within 2 years prior to Screening.
Administration of any prescription or non-prescription drugs (including antacids; however, acetaminophen at a dose ≤ 1 g/day is permitted), herbal remedies or vitamin supplements from 28 days, or five half-lives, whichever is longer, prior to Admission.
Clareo Health | A Study of LY4064809 [14C]-STX-478 in Healthy Male Participants
